Profound Medical Corp at Raymond James Human Health Innovation Conference (Virtual) Transcript
Good morning, everyone. Thank you so much for joining us today. My name is Rahul Sarugaser. I'm a med tech analyst with Raymond James based in the Toronto office.
I've been covering Profound Medical for the last few years. It's a company we have quite strong conviction in as it has been commercializing its device, TULSA-PRO, primarily for treatment of prostate cancer but of course broadening its utility in other prostate indications.
We have the pleasure today of Arun Menawat, Dr. Menawat, the President and CEO of the Company, who has a few opening remarks, and then we will be diving right into a fireside chat. So Arun?
Rahul, thank you so much. Thank you for inviting us, and thank you for giving me the opportunity to make the opening remarks.
I'd like to start today with a patient testimonial, and that patient happens to be me. I know my prostate has been growing for the last few years, but the PSA was
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |